MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled clinical trial to assess the efficacy and safety of a
combination of lopinavir/ritonavir and Interferon beta-1b in hospitalized patients with MERS.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
King Abdullah International Medical Research Center